Intrinsiqs

Is Bicara Therapeutics Inc. Common Stock overvalued?

Bicara Therapeutics Inc. Common Stock (BCAX) — key valuation metrics and fundamentals.

No verdict
Price
$23.83
Fair value
Current P/E
Normal P/E
Market cap
$1.57B
Dividend yield
0.0%
Return on equity
-41.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares BCAX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.